Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 Guidance

July 30, 2026 7:00 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $2.04, $0.43 better than the analyst estimate of $1.61. Revenue for the quarter came in at $12.97 billion versus the consensus estimate of $11.71 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2026 EPS of $6.75-$7.00, versus the consensus of $6.34.... More